Skip to content

Clinical trials

Ischemic Attack, Transient trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ischemic Attack, Transient Country / region: South Korea Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20091
20101
20111
20143
20161
20181
20191
20201
20211
20241
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting2
Terminated2
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Asan Medical Center2
Bayer2
Astellas Pharma Inc1
Boryung Pharmaceutical Co., Ltd1
Bristol-Myers Squibb1
Ewha Womans University Mokdong Hospital1
HUINNO Co., Ltd1
Hanyang University Guri Hospital1
Seoul National University Boramae Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ischemic Attack, Transient16
Ischemic Stroke10
Stroke7
Atrial Fibrillation3
Cerebrovascular Disorders3
Thromboembolism2
Antiphospholipid Syndrome1
Arrhythmias, Cardiac1
Cardiovascular Diseases1
Carotid Stenosis1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.